Literature DB >> 23478864

Biochemical characteristics and risk factors for insulin resistance at different levels of obesity.

Fernando Guerrero-Romero1, Celia Aradillas-García, Luis E Simental-Mendía, María L Torres-Rodríguez, Esperanza de la Cruz Mendoza, Janneth Rosales-Cervantes, Gabriela Rodríguez-Ramírez, Martha Rodríguez-Moran.   

Abstract

OBJECTIVE: To establish the biochemical characteristics of nonobese, overweight, and obese children as well as to determine the risk factors associated with insulin resistance in nonobese children and with non-insulin resistance in obese children in the age strata of 6 to 11 years.
METHODS: A total of 3512 healthy children were enrolled in a cross-sectional study. In the absence of obesity, fasting hyperinsulinemia and hypertriglyceridemia defined nonobese, insulin-resistant (NO-IR) children. In the absence of metabolic abnormalities of fasting insulin and triglycerides levels, obese children were defined as obese, not insulin-resistant (O-NIR) children.
RESULTS: The gender- and age-adjusted prevalence of NO-IR and O-NIR was 6.6% and 21.3%, respectively. In the age-, gender-, and birth weight-adjusted analysis, family history of hypertension (FHH) in both maternal and paternal branches (odds ratio [OR]: 1.514; 95% confidence interval [CI]: 1.2-3.9; P = .04) was associated with NO-IR children. In the analysis adjusted by gender, age, waist circumference (WC), BMI, FHH, and family history of diabetes, high birth weight was associated with NO-IR children (OR: 1.319; 95% CI: 1.2-2.1; P = .04). Finally, in the gender-, age-, family history-, and birth weight-adjusted analysis, a WC lower than the 95th percentile was associated with a lower odds of insulin resistance among obese children (OR: 0.96; 95% CI: 0.91-0.98; P < .0005).
CONCLUSIONS: FHH and high birth weight are associated with NO-IR children, and a low WC is associated with lower odds of O-IR children.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23478864     DOI: 10.1542/peds.2012-1421

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  6 in total

1.  Relationship between elevated triglyceride levels with the increase of HOMA-IR and HOMA-β in healthy children and adolescents with normal weight.

Authors:  Luis E Simental-Mendía; Argelia Castañeda-Chacón; Martha Rodriguez-Morán; Celia Aradillas-García; Fernando Guerrero-Romero
Journal:  Eur J Pediatr       Date:  2014-10-23       Impact factor: 3.183

2.  The triglycerides and glucose index is associated with cardiovascular risk factors in normal-weight children and adolescents.

Authors:  Luis E Simental-Mendía; Gabriela Hernández-Ronquillo; Rita Gómez-Díaz; Martha Rodríguez-Morán; Fernando Guerrero-Romero
Journal:  Pediatr Res       Date:  2017-08-30       Impact factor: 3.756

Review 3.  Children With Metabolically Healthy Obesity: A Review.

Authors:  Rade Vukovic; Tiago Jeronimo Dos Santos; Marina Ybarra; Muge Atar
Journal:  Front Endocrinol (Lausanne)       Date:  2019-12-10       Impact factor: 5.555

4.  Hypertension in adolescents: The role of obesity and family history.

Authors:  Weiying Zhao; Luxia Mo; Yusheng Pang
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-11-16       Impact factor: 3.738

5.  Flavonol-rich dark cocoa significantly decreases plasma endothelin-1 and improves cognition in urban children.

Authors:  Lilian Calderón-Garcidueñas; Antonieta Mora-Tiscareño; Maricela Franco-Lira; Janet V Cross; Randall Engle; Mariana Aragón-Flores; Gilberto Gómez-Garza; Valerie Jewells; Humberto Medina-Cortina; Edelmira Solorio; Chih-Kai Chao; Hongtu Zhu; Partha S Mukherjee; Lara Ferreira-Azevedo; Ricardo Torres-Jardón; Amedeo D'Angiulli
Journal:  Front Pharmacol       Date:  2013-08-22       Impact factor: 5.810

6.  Metabolic Profiles in Obese Children and Adolescents with Insulin Resistance.

Authors:  Marko Kostovski; Viktor Simeonovski; Kristina Mironska; Velibor Tasic; Zoran Gucev
Journal:  Open Access Maced J Med Sci       Date:  2018-03-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.